Gene-smoking interaction on colorectal adenoma and cancer risk: Review and meta-analysis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 670, Issue 1-2, 2009, Pages 6-14

  Raimondi, Sara ^a   Botteri, Edoardo ^a   Iodice, Simona ^a   Lowenfels, Albert B ^b   Maisonneuve, Patrick ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Colorectal polyps; Gene environment interaction; Genetic epidemiology; Meta analysis; Metabolic gene polymorphisms

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HISTONE H3; HISTONE H4; TOBACCO SMOKE;

ARTICLE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; COLORECTAL ADENOMA; COLORECTAL CANCER; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOKINETICS;

ADENOMA; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; RISK; SMOKING;

NICOTIANA TABACUM;

EID: 70350020289     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.06.013     Document Type: Article

References (64)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Desai T.K., and Barkel D. Syndromic colon cancer: lynch syndrome and familial adenomatous polyposis. Gastroenterol. Clin. N. Am. 37 (2008) 47-72 vi
3. de Jong M.M., Nolte I.M., te Meerman G.J., van der Graaf W.T., de Vries E.G., Sijmons R.H., Hofstra R.M., and Kleibeuker J.H. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1332-1352
4. Cotton S., Sharp L., and Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit. Rev. Oncog. 7 (1996) 293-342
5. Mulder J.W., Offerhaus G.J., de Feyter E.P., Floyd J.J., Kern S.E., Vogelstein B., and Hamilton S.R. The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am. J. Pathol. 141 (1992) 797-804
6. Gandini S., Botteri E., Iodice S., Boniol M., Lowenfels A.B., Maisonneuve P., and Boyle P. Tobacco smoking and cancer: a meta-analysis. Int. J. Cancer 122 (2008) 155-164
7. Botteri E., Iodice S., Raimondi S., Maisonneuve P., and Lowenfels A.B. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134 (2008) 388-395
8. Botteri E., Iodice S., Bagnardi V., Raimondi S., Lowenfels A.B., and Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 300 (2008) 2765-2778
9. Gram I.T., Braaten T., Lund E., Le Marchand L., and Weiderpass E. Cigarette smoking and risk of colorectal cancer among Norwegian women. Cancer Causes Control 20 (2009) 895-903
10. Wu I.C., Lee C.H., Kuo C.H., Kuo F.C., Wu D.C., Ko Y.C., and Yu F.J. Consumption of cigarettes but not betel quid or alcohol increases colorectal cancer risk. J. Formos Med. Assoc. 108 (2009) 155-163
11. Tsoi K.K., Pau C.Y., Wu W.K., Chan F.K., Griffiths S., and Sung J.J. Cigarette smoking and the risk of colorectal cancer: A meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol. 7 (2009) 682-688
12. Liang P.S., Chen T.Y., and Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int. J. Cancer 124 (2009) 2406-2415
13. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3 (2003) 733-744
14. Wogan G.N., Hecht S.S., Felton J.S., Conney A.H., and Loeb L.A. Environmental and chemical carcinogenesis. Semin. Cancer Biol. 14 (2004) 473-486
15. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91 (1999) 1194-1210
16. Kiyohara C., Otsu A., Shirakawa T., Fukuda S., and Hopkin J.M. Genetic polymorphisms and lung cancer susceptibility: A review. Lung Cancer 37 (2002) 241-256
17. Kelada S.N., Eaton D.L., Wang S.S., Rothman N.R., and Khoury M.J. The role of genetic polymorphisms in environmental health. Environ. Health Perspect. 111 (2003) 1055-1064
18. Kraft P., and Hunter D. Integrating epidemiology and genetic association: the challenge of gene-environment interaction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 (2005) 1609-1616
19. Taioli E., and Raimondi S. Genetic susceptibility to bladder cancer. Lancet 366 (2005) 610-612
20. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21 (2002) 1539-1558
21. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
22. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 6 (1997) 733-743
23. Yoshida K., Osawa K., Kasahara M., Miyaishi A., Nakanishi K., Hayamizu S., Osawa Y., Tsutou A., Tabuchi Y., Shimada E., Tanaka K., Yamamoto M., and Takahashi J. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J. Cancer Prev. 8 (2007) 438-444
24. van der Hel O.L., Bueno de Mesquita H.B., Roest M., Slothouber B., van Gils C., van Noord P.A., Grobbee D.E., and Peeters P.H. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol. Biomark. Prev. 12 (2003) 681-682
25. Oesch F. Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3 (1973) 305-340
26. Pastorelli R., Guanci M., Cerri A., Negri E., La Vecchia C., Fumagalli F., Mezzetti M., Cappelli R., Panigalli T., Fanelli R., and Airoldi L. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol. Biomark. Prev. 7 (1998) 703-709
27. Hassett C., Aicher L., Sidhu J.S., and Omiecinski C.J. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3 (1994) 421-428
28. Robien K., Curtin K., Ulrich C.M., Bigler J., Samowitz W., Caan B., Potter J.D., and Slattery M.L. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol. Biomark. Prev. 14 (2005) 1350-1352
29. Ulrich C.M., Bigler J., Whitton J.A., Bostick R., Fosdick L., and Potter J.D. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol. Biomark. Prev. 10 (2001) 875-882
30. Tiemersma E.W., Bunschoten A., Kok F.J., Glatt H., de Boer S.Y., and Kampman E. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int. J. Cancer 108 (2004) 97-103
31. Tranah G.J., Giovannucci E., Ma J., Fuchs C., Hankinson S.E., and Hunter D.J. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 25 (2004) 1211-1218
32. Cortessis V., Siegmund K., Chen Q., Zhou N., Diep A., Frankl H., Lee E., Zhu Q.S., Haile R., and Levy D. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res. 61 (2001) 2381-2385
33. Huang W.Y., Chatterjee N., Chanock S., Dean M., Yeager M., Schoen R.E., Hou L.F., Berndt S.I., Yadavalli S., Johnson C.C., and Hayes R.B. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol. Biomark. Prev. 14 (2005) 152-157
34. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., and Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomark. Prev. 9 (2000) 3-28
35. van der Hel O.L., Bueno de Mosquita H.B., Sandkuijl L., van Noord P.A., Pearson P.L., Grobbee D.E., and Peeters P.H. Rapid N-acetyltransferase 2 imputed phenotype and smoking may increase risk of colorectal cancer in women (Netherlands). Cancer Causes Control. 14 (2003) 293-298
36. Probst-Hensch N.M., Haile R.W., Ingles S.A., Longnecker M.P., Han C.Y., Lin B.K., Lee D.B., Sakamoto G.T., Frankl H.D., and Lee E.R. Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res. 55 (1995) 2017-2020
37. Dong L.M., Potter J.D., White E., Ulrich C.M., Cardon L.R., and Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299 (2008) 2423-2436
38. Cajas-Salazar N., Au W.W., Zwischenberger J.B., Sierra-Torres C.H., Salama S.A., Alpard S.K., and Tyring S.K. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. Cancer Genet. Cytogenet. 145 (2003) 97-102
39. Lee K.M., Kang D., Clapper M.L., Ingelman-Sundberg M., Ono-Kihara M., Kiyohara C., Min S., Lan Q., Le Marchand L., Lin P., Lung M.L., Pinarbasi H., Pisani P., Srivatanakul P., Seow A., Sugimura H., Tokudome S., Yokota J., and Taioli E. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol. Biomark. Prev. 17 (2008) 1120-1126
40. Ochs-Balcom H.M., Wiesner G., and Elston R.C. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. Am. J. Epidemiol. 166 (2007) 246-254
41. Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., Oude Ophuis M.B., Benhamou S., Foulkes W.D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., and Boffetta P. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1509-1517
42. Cotton S.C., Sharp L., Little J., and Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151 (2000) 7-32
43. Brockton N., Little J., Sharp L., and Cotton S.C. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 151 (2000) 846-861
44. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J. Epidemiol. 10 (2000) 349-360
45. Ioannidis J.P., Boffetta P., Little J., O'Brien T.R., Uitterlinden A.G., Vineis P., Balding D.J., Chokkalingam A., Dolan S.M., Flanders W.D., Higgins J.P., McCarthy M.I., McDermott D.H., Page G.P., Rebbeck T.R., Seminara D., and Khoury M.J. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 37 (2008) 120-132
46. Lin H.J., Probst-Hensch N.M., Ingles S.A., Han C.Y., Lin B.K., Lee D.B., Frankl H.D., Lee E.R., Longnecker M.P., and Haile R.W. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res. 55 (1995) 1224-1226
47. Inoue H., Kiyohara C., Marugame T., Shinomiya S., Tsuji E., Handa K., Hayabuchi H., Onuma K., Hamada H., Koga H., and Kono S. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res. 60 (2000) 3749-3752
48. Moore L.E., Huang W.Y., Chatterjee N., Gunter M., Chanock S., Yeager M., Welch B., Pinsky P., Weissfeld J., and Hayes R.B. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol. Biomark. Prev. 14 (2005) 1823-1827
49. Gertig D.M., Stampfer M., Haiman C., Hennekens C.H., Kelsey K., and Hunter D.J. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol. Biomark. Prev. 7 (1998) 1001-1005
50. Yoshioka M., Katoh T., Nakano M., Takasawa S., Nagata N., and Itoh H. Glutathione S-transferase (GST) M1, T1, P1, N-acetyltransferase (NAT) 1 and 2 genetic polymorphisms and susceptibility to colorectal cancer. J. UOEH 21 (1999) 133-147
51. Slattery M.L., Edwards S., Curtin K., Schaffer D., and Neuhausen S. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol. Biomark. Prev. 12 (2003) 882-889
52. Smits K.M., Gaspari L., Weijenberg M.P., Dolzan V., Golka K., Roemer H.C., Nedelcheva K., Kristensen V., Lechner M.C., Mehling G.I., Seidegard J., Strange R.C., and Taioli E. Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers 8 (2003) 299-310
53. Ates N.A., Tamer L., Ates C., Ercan B., Elipek T., Ocal K., and Camdeviren H. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem. Genet. 43 (2005) 149-163
54. Huang K., Sandler R.S., Millikan R.C., Schroeder J.C., North K.E., and Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control. 17 (2006) 385-394
55. Inoue H., Kiyohara C., Shinomiya S., Marugame T., Tsuji E., Handa K., Hayabuchi H., Eguchi H., Fukushima Y., and Kono S. Glutathione S-transferase polymorphisms and risk of colorectal adenomas. Cancer Lett. 163 (2001) 201-206
56. Yeh C.C., Hsieh L.L., Tang R., Chang-Chieh C.R., and Sung F.C. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J. Gastroenterol. 11 (2005) 1473-1480
57. Mitrou P.N., Watson M.A., Loktionov A.S., Cardwell C., Gunter M.J., Atkin W.S., Macklin C.P., Cecil T., Bishop D.T., Primrose J., and Bingham S.A. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis 28 (2007) 875-882
58. Tiemersma E.W., Kloosterman J., Bunschoten A., Kok F.J., and Kampman E. Role of EPHX genotype in the associations of smoking and diet with colorectal adenomas. IARC Sci. Publ. 156 (2002) 491-493
59. Potter J.D., Bigler J., Fosdick L., Bostick R.M., Kampman E., Chen C., Louis T.A., and Grambsch P. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol. Biomark. Prev. 8 (1999) 69-75
60. Moslehi R., Chatterjee N., Church T.R., Chen J., Yeager M., Weissfeld J., Hein D.W., and Hayes R.B. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 7 54 (2006) 819-829
61. Slattery M.L., Potter J.D., Samowitz W., Bigler J., Caan B., and Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 7 (1998) 1079-1084
62. Le Marchand L., Hankin J.H., Wilkens L.R., Pierce L.M., Franke A., Kolonel L.N., Seifried A., Custer L.J., Chang W., Lum-Jones A., and Donlon T. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomark. Prev. 10 (2001) 1259-1266
63. Barrett J.H., Smith G., Waxman R., Gooderham N., Lightfoot T., Garner R.C., Augustsson K., Wolf C.R., Bishop D.T., and Forman D. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 24 (2003) 275-282
64. Lilla C., Verla-Tebit E., Risch A., Jager B., Hoffmeister M., Brenner H., and Chang-Claude J. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol. Biomark. Prev. 15 (2006) 99-107